Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. - Wikidata - wikimedia - TriplyDB

Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.

Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.

http://www.wikidata.org/entity/Q33721979

about

Organic-inorganic composites for bone drug delivery.(18)F-FDG microPET imaging differentiates between septic and aseptic wound healing after orthopedic implant placement: a longitudinal study of an implant osteomyelitis in the rabbit tibia.(68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections A resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect model A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia.Biomaterials approaches to treating implant-associated osteomyelitis.Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.Antibacterial effect of 317L stainless steel contained copper in prevention of implant-related infection in vitro and in vivo.Insights on the properties of levofloxacin-adsorbed Sr- and Mg-doped calcium phosphate powders.Efficacy of vancomycin-releasing biodegradable poly(lactide-co-glycolide) antibiotics beads for treatment of experimental bone infection due to Staphylococcus aureus.Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles.Polymer-controlled release of tobramycin from bone graft void filler.Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model.A controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilm.Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.Bioactive composites fabricated by freezing-thawing method for bone regeneration applications Scaffolds as Structural Tools for Bone-Targeted Drug Delivery

P2860

Q33563523-0B4D9673-8D19-4C1C-A84A-48CE8C553EE8 Q33775018-DD84CA50-956E-47ED-A7AC-ACE69E09B627 Q34699288-72604504-997C-440C-9F4D-6AC8024ED943 Q35225221-A897C8AD-B59A-426B-8215-D6E7F67C9E8D Q36150256-95BED22E-1988-435D-8B75-05917A8D9B76 Q36555710-0AC642E4-8D44-483C-B9C2-3E953A1DC399 Q36597452-15440D4F-625D-46DB-92DD-D5BA124D65E5 Q37111778-371582EC-95AF-45A5-B517-59B0D60F7EC9 Q39484136-222B0E87-2154-4EAA-87A4-FDD4FB57BCB3 Q39684601-6C6B60A1-37B7-4AF2-B9DB-486C6F9B6AD4 Q39816004-0EA2CFC7-CD6B-4130-8CEB-26F54C1252F0 Q41125275-4452A306-B2D3-420C-9CCE-0B0BCBEAE9B5 Q41197707-241C0388-6254-4FB7-BEC8-54FE4399024E Q41586328-C4155158-0B2E-476D-82DA-94E09FD3BF8A Q41688660-35043D5B-26A3-41B3-BF17-AA83FC1F20ED Q45173405-6B8244C3-B47E-457B-A710-5D509EE67714 Q46592560-EAE170A5-96FB-4003-AA8B-D5BB0878A178 Q57345079-3888AA94-6B0F-4381-927A-6ED6B0D4208A Q58794823-719826CF-BF1E-4BC9-88F5-3E4528BE2A12

P2860

Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.

http://www.wikidata.org/entity/Q33721979

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.

@ast

Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.

@en

type

label

Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.

@ast

Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.

@en

prefLabel

Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.

@ast

Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.

@en

P1433

Q33721979-86D5140E-AF4B-4179-ABA6-A009033B5CF3

P1476

Q33721979-C2F49C31-E886-4E66-9B56-892BC274AC54

P2093

Q33721979-0345ABAA-5CCA-4916-BEB2-95E94C9B3F56

Q33721979-251D2E4A-126D-4328-A630-8EA1F4665937

Q33721979-5A6EA51F-A2D9-4BFD-9989-D3DB9FEB43BB

Q33721979-ABBBC17F-33E5-4B58-962A-40C945DD908E

Q33721979-B67A31BF-FA5D-4C3C-9167-48A4E93DAF51

Q33721979-D8A8EE14-49EE-4404-AFC4-126BF4E702F6

P2860

Q33721979-015D759E-ACCF-49EB-A096-95E712A42669

Q33721979-03EB05CB-4B70-48E7-839A-FAC192A57855

Q33721979-07705F57-F651-40C9-B8E3-8B78F1AB03EF

Q33721979-110AFFD2-BEF0-44A8-BF02-F979BD7B85BF

Q33721979-2574C1C1-5646-46A5-B4B8-BA11EBCF17A0

Q33721979-3B9E098E-5EEB-4A3F-97A3-F67C749AB0B3

Q33721979-3E8245B5-2B77-4ADE-BAEF-C04C29F27398

Q33721979-4398363A-91A8-41FA-A709-B534AB8D0052

Q33721979-4C57ADA2-ABE8-4F61-AD9D-5F9B02EDC07D

Q33721979-5E04B249-2F5B-41AD-8088-DB425C0E04B6

P304

Q33721979-99072020-A49E-4815-AEDE-4D5AE237C06F

P31

Q33721979-7194A420-0330-403E-A475-CE4BA4F479E7

P356

Q33721979-5E2F35E6-EC60-4235-A323-91A904273240

P407

Q33721979-291D4F3A-00AF-4389-85D4-E9D92F2450CC

P433

Q33721979-D34E1D30-8E44-4ADB-B4A6-C854ADA92B53

P478

Q33721979-DD7F7ADA-F6C1-4224-BF12-EC136F3B4B69

P50

Q33721979-49063382-5317-44C0-8726-3713F98D71F5

Q33721979-82ECEB94-4C30-4248-AD2D-4E462E3D5538

P577

Q33721979-5CEB304A-3420-4EB6-AFA8-60D5C598B052

P5875

Q33721979-26194016-2A98-4CC9-A99F-120F32E43E21

P698

Q33721979-F81D9295-0D60-4358-9E46-14AEB20EB335

P932

Q33721979-53110A63-E154-446A-8E8E-28603ED76137

P356

AAC.49.4.1502-1508.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Efficacy of ciprofloxacin-rele ...... due to Staphylococcus aureus.

@en

P2093

Esa Suokas

http://www.w3.org/2001/XMLSchema#string

Jari Jalava

http://www.w3.org/2001/XMLSchema#string

Jyri K Koort

http://www.w3.org/2001/XMLSchema#string

Minna Veiranto

http://www.w3.org/2001/XMLSchema#string

Pertti Törmälä

http://www.w3.org/2001/XMLSchema#string

Tatu J Mäkinen

http://www.w3.org/2001/XMLSchema#string

P2860

Carrier systems for the local delivery of antibiotics in bone infections.

Newer methods of antimicrobial delivery for bone and joint infections.

In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads

Role of oral antimicrobial therapy in the management of osteomyelitis.

Animal models of osteomyelitis. Knowledge, hypothesis, and speculation.

In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.

Treatment of osteomyelitis with a biodegradable antibiotic implant.

Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties.

Bioactive ceramics.

Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study.

P304

1502-1508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.4.1502-1508.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7943035

http://www.w3.org/2001/XMLSchema#string

P698

15793132

http://www.w3.org/2001/XMLSchema#string

P932

1068592

http://www.w3.org/2001/XMLSchema#string